Notícias

Shares have performed exceptionally well in the past 12 months, which is an aberration.

In the closing of the recent trading day, V.F. (VFC) stood at $16.53, denoting a -3.73% move from the preceding trading day.

The hottest tech trades of 2026 just got slammed — smart investors are buying anyway.

In the most recent trading session, Symbotic Inc. (SYM) closed at $40.57, indicating a -4.45% shift from the previous trading day.

In the most recent trading session, Rigetti Computing, Inc. (RGTI) closed at $14.85, indicating a -2.5% shift from the previous trading day.

In the latest trading session, Star Bulk Carriers (SBLK) closed at $27.15, marking a +1.42% move from the previous day.

In the most recent trading session, ConocoPhillips (COP) closed at $120.2, indicating a +1.19% shift from the previous trading day.

On July 23, 2026, the steelmaker told investors to expect earnings to continue improving.

Franklin Resources has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.8%. The stock now trades at $32.49, marking a 28.4% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

<p>That EM ETF you added to your portfolio years ago for diversification purposes may actually just be delivering more of what you’re already getting an overabundance of via domestic equities: tech. The RISE ETF offers a genuinely differentiated approach to EM investing that won’t deliver 40% tech sector exposure (it’s just 5% of the fund). Tune into this episode of <em>Behind the Ticker</em> to learn more. </p>

Nvidia is looking attractively priced.

DHT Holdings currently trades at $18.16 and has been a dream stock for shareholders. It’s returned 214% since July 2021, more than tripling the S&P 500’s 70.1% gain. The company has also beaten the index over the past six months as its stock price is up 31.4% thanks to its solid quarterly results.

On July 23, 2026, massive capital expenditure plans triggered a broad retreat across technology stocks, as soaring crude oil added to inflation fears.

U.S. stocks fell sharply as global oil prices topped $100 a barrel for the first time in two months and earnings from Alphabet and Tesla rekindled AI spending fears.

Today, July 23, 2026, analysts cut price targets as margin pressure and autonomous-driving caution weigh on the EV leader.

Pediatrix Medical Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.3%. The stock now trades at $25.83, marking a 19.9% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

The Nasdaq undercut key levels as Google and Tesla led titans lower while oil prices soared. A big SpaceX launch is due.

(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit

While Wall Street debates which AI giant wins next, a quieter rotation is rewarding investors who never bought into the hype, and three dividend-paying value ETFs are making the case that boring beats flashy in 2026.

FTXO delivered 28.40% returns over one year with lower costs, while UYG's leveraged structure produced 7.81%.

Newmont reported better-than-expected second-quarter earnings, despite weaker gold prices. Cost control helped. Through Thursday trading, Newmont stock has been strong, up almost 60% over the past 12 months, benefiting from the rise in gold prices.

SpaceX stock rose as investors were waiting for an all-important Starship test flight, slated for later on Thursday. SpaceX trades for roughly 40 times estimated 2026 sales, and there has simply never been a trillion-dollar company at that valuation. Investors hope Starship can send the stock back into orbit.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

One basis point separates these two healthcare funds. Here is why the bigger decision is whether to own healthcare at all.

Your portfolio might lose value, but that doesn't tell the whole story.

(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit

VanEck's concentrated biotech portfolio surged 30.8% in one year but endured a 39.9% drawdown. iShares offers steadier global healthcare exposure with a 1.5% dividend yield.

The stock market has posted many double-digit gains in recent years. You might still want to invest in it.

The networking giant is standing out in a weak market, but what it really offers your portfolio is a powerful, and volatile, dose of something new.

with rising crude prices one of the most salient risks to the market right now, that exposure isn’t really such a bad thing.